Eufy Scale Visceral Fat: Readings Explained

Eufy scale visceral fat readings give millions of people a window into one of the most clinically significant aspects of body composition. Visceral fat, stored deep around the abdominal organs, carries greater health risks than surface-level fat and is linked to type 2 diabetes, cardiovascular disease and metabolic conditions. The Eufy smart scale estimates visceral fat using bioelectrical impedance analysis, providing a numerical index through the EufyLife app. This article explains how the technology works, what your readings mean, how they compare to NHS assessments, and what you can do to reduce visceral fat safely and effectively.

What is visceral fat and why does it matter for your health?

Visceral fat is stored deep within the abdominal cavity around organs such as the liver and pancreas, and excess levels are associated with type 2 diabetes, cardiovascular disease and metabolic conditions. NICE recognises body composition as an important health indicator alongside BMI.

Visceral fat is the fat stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines, and it carries greater health risks than subcutaneous fat stored just beneath the skin. Unlike the fat you can pinch at your waist, visceral fat is metabolically active, releasing hormones and inflammatory compounds that can disrupt normal organ function over time.

Excess visceral fat is associated with an increased risk of several serious conditions, including:

• Type 2 diabetes

• Cardiovascular disease

• High blood pressure

• Metabolic dysfunction-associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease or NAFLD)

• Certain cancers

NICE guidance on obesity and cardiometabolic risk recognises that waist circumference and body composition are important indicators of health risk, not just body mass index (BMI) alone.^[1][2] A person can have a BMI within the normal range and still carry a clinically significant amount of visceral fat, a pattern sometimes described as being "metabolically obese."

Because visceral fat is not visible and cannot be felt, many people are unaware of how much they carry. Consumer body composition scales can offer a way of tracking body fat trends over time, but it is important to note that these are wellness devices rather than medical diagnostic tools, and their readings should not be used in place of a clinical assessment. Understanding your visceral fat trend may nonetheless be a useful prompt to make lifestyle changes or seek professional advice from your GP.

How does the Eufy scale measure visceral fat?

The Eufy scale estimates visceral fat using bioelectrical impedance analysis (BIA), which measures electrical resistance through body tissue and uses your height, weight, age and sex to calculate a visceral fat index. Single readings can be affected by hydration, exercise and time of day.

The Eufy smart scale estimates visceral fat using a technique called bioelectrical impedance analysis (BIA), which works by passing a low-level electrical current through the body and measuring the resistance encountered. Fat tissue, muscle and water conduct electricity differently, allowing the device to estimate body composition from the impedance readings.

The scale uses these impedance values alongside personal data you enter into the EufyLife app, typically your height, weight, age and sex, to calculate an estimated visceral fat level. The result is expressed as a numerical index rather than a direct measurement in grams or kilograms. This index is generated by an algorithm that compares your readings against population reference data.

It is important to understand that BIA does not directly visualise or measure visceral fat. The technology cannot distinguish precisely between visceral and subcutaneous abdominal fat; instead, it infers visceral fat from total body fat distribution patterns. Several factors can affect the accuracy of a single reading, including:

• Hydration status (dehydration raises impedance artificially)

• Time of day and recent food or fluid intake

• Exercise in the hours before measurement

• Skin temperature

Readings may also be unreliable during pregnancy, in people with significant fluid shifts (for example, those with heart failure or kidney disease), and in older adults or those with very high or very low muscle mass.^[15] In these situations, a clinical assessment is more appropriate than relying on a consumer BIA device.

Safety note: Most BIA device manufacturers, including Eufy, advise that people with implanted cardiac devices such as pacemakers or implantable cardioverter-defibrillators (ICDs), or other implanted electronic devices, should consult their clinician or the device manufacturer before using a BIA scale. If this applies to you, please check with your GP or specialist before use.

For most healthy adults, Eufy and similar manufacturers recommend measuring at the same time each day, ideally in the morning before eating or drinking, to ensure readings are as consistent as possible. Trends over weeks and months are more informative than any single data point.

What do your Eufy visceral fat readings actually mean?

The Eufy visceral fat index is a relative indicator of internal fat level, not an absolute clinical measurement, and should be interpreted as a trend over time rather than a single definitive figure. A consistently high index is a reasonable prompt to book a GP health check.

The Eufy scale displays visceral fat as a numerical index, and the EufyLife app categorises this into broad ranges to help you interpret your result. According to Eufy's own app documentation, a reading in the lower range is generally considered healthy, a reading in the mid-range suggests a borderline or elevated level warranting attention, and readings above this threshold indicate a high visceral fat level that may carry meaningful health risk. The specific numerical bands shown in the app may vary between Eufy models and app versions; refer to your device's user manual or the EufyLife app help centre for the figures that apply to your scale.

It is important to note that visceral fat indices are not standardised across manufacturers or models. A reading from a Eufy scale cannot be directly compared with a reading from a different brand, and these indices do not map onto the clinical cut-offs used in NHS assessments or research studies. You should treat your Eufy visceral fat index as a relative indicator of your internal fat level rather than an absolute clinical measurement, and you should not use it alone to start, stop or adjust any medication or treatment.

When reviewing your readings, consider the following:

• Trend over time is more meaningful than a single number. A consistently falling index over several months suggests your lifestyle changes are working.

• Context matters. A borderline reading in someone who is otherwise active and has no metabolic risk factors carries different implications than the same reading in someone with high blood pressure or raised blood glucose.

• Use complementary measures. Checking your waist circumference alongside your Eufy readings gives a practical, clinically recognised picture of your abdominal fat level.

• Discuss significant readings with your GP. If your Eufy scale consistently shows a high visceral fat index, this is a reasonable prompt to book a health check, where your GP can assess your cardiovascular and metabolic risk more comprehensively.

How accurate is the Eufy scale compared to NHS health assessments?

The Eufy scale can track directional changes in body fat reasonably well but is less accurate than gold-standard methods such as MRI, CT or DEXA scanning. NHS assessments typically use waist circumference, waist-to-height ratio and BMI as practical proxy measures.

The Eufy scale provides a useful estimate of visceral fat trends but is not as accurate as the clinical methods used in NHS or research settings. The gold standard for measuring visceral fat is magnetic resonance imaging (MRI) or computed tomography (CT) scanning, which can directly visualise and quantify fat deposits around the organs. Dual-energy X-ray absorptiometry (DEXA) scanning is also used in clinical research and some specialist NHS services. None of these are routinely available for visceral fat monitoring in primary care.

In practice, NHS health assessments typically use proxy measures rather than direct imaging. These include:

• Waist circumference, which NICE guidance identifies as a practical indicator of abdominal adiposity

• Waist-to-hip ratio

• Waist-to-height ratio, which NHS resources increasingly recommend as a practical measure of central adiposity for adults

• BMI, used alongside clinical judgement

Research comparing BIA-based consumer scales with DEXA or MRI has generally found that BIA can track directional changes in body fat reasonably well at a population level, but individual readings can vary considerably from gold-standard measurements.^[13][15] The margin of error is larger in people at the extremes of body composition, in older adults, and in those with conditions affecting fluid balance, such as kidney disease or heart failure.

For most healthy adults using the Eufy scale at home, the device offers a practical and accessible way to monitor body composition trends over time. However, it should not be used to make clinical decisions, and any concerns about your visceral fat level or metabolic health should be discussed with your GP, who can arrange appropriate investigations.

What is a healthy visceral fat level and how can you reduce it?

NICE and NHS guidance uses waist circumference as a practical proxy for abdominal fat risk, with action thresholds varying by sex and ethnicity. Visceral fat responds well to aerobic exercise, dietary changes, adequate sleep and reduced alcohol intake.

The EufyLife app defines its own healthy range for the visceral fat index it displays; refer to your device's user manual or the app help centre for the specific figures that apply to your model, as these are device-defined thresholds rather than clinical diagnostic criteria.

From a clinical perspective, NICE and NHS guidance focuses on waist circumference as a practical proxy for abdominal fat. For most adults, a waist circumference below 94 cm (men) or 80 cm (women) is associated with lower cardiometabolic risk, with measurements above 102 cm (men) or 88 cm (women) indicating substantially increased risk.^[1][2] Lower thresholds apply to people of South Asian, Chinese, Japanese and some other ethnic backgrounds, for whom NHS guidance recommends using 90 cm (men) or 80 cm (women) as the action threshold.^[3] If you are unsure which thresholds apply to you, your GP can advise.

Visceral fat responds well to lifestyle modification, and the evidence base for the following approaches is robust:

• Regular aerobic exercise. Activities such as brisk walking, cycling and swimming are particularly effective at reducing visceral fat, even when total body weight changes little.^[17][18] NHS guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults.^[6][7]

• Resistance training. Building muscle mass improves insulin sensitivity and supports long-term fat reduction.

• Dietary changes. Reducing ultra-processed foods, added sugars and refined carbohydrates, while increasing fibre, vegetables and lean protein, is associated with meaningful reductions in visceral fat. The NHS Eatwell Guide provides practical advice on a balanced diet.

• Adequate sleep. Poor sleep is independently associated with increased visceral fat accumulation.

• Reducing alcohol intake. Alcohol contributes to abdominal fat deposition. The UK Chief Medical Officers advise keeping alcohol consumption to no more than 14 units per week, spread across three or more days, to keep health risks low.

For people with a BMI of 35 or above alongside weight-related health conditions, or a BMI of 40 or above, NICE-recommended weight management interventions may be considered. Eligibility for pharmacological treatment or specialist weight management services depends on individual NICE Technology Appraisals and local Integrated Care Board (ICB) commissioning decisions, so access and criteria can vary. Your GP is best placed to advise on which options may be appropriate for you and to refer you through the correct pathway.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a range of treatment options may be considered if clinically appropriate following assessment. If your Eufy readings remain persistently elevated despite lifestyle changes, speak to your GP about a formal health review.

Scientific References

1. Overweight and obesity management (NG246): Identifying and assessing overweight, obesity and central adiposity.
2. Overweight and obesity management (NG246).
3. NG246 Appendix A1: Summary of evidence from surveillance – waist circumference thresholds for South Asian and Chinese populations.
4. Keep the size of your waist to less than half of your height – NICE recommends.
5. Overweight and obesity in adults.
6. Physical activity guidelines for adults aged 19 to 64.
7. Exercise – NHS Live Well.
8. Drink less alcohol – Better Health – NHS.
9. Bone density scan (DEXA scan) – When it is used.
10. Alcohol consumption: advice on low risk drinking.
11. Chapter 12: alcohol – Delivering Better Oral Health: an evidence-based toolkit for prevention.
12. Using dual energy x-ray absorptiometry (DEXA) scans for non-medical purposes as a justified practice.
13. Schoeller DA. Bioelectrical impedance analysis: what does it measure? Am J Clin Nutr. 2000..
14. Saunders MJ et al. Effects of hydration changes on bioelectrical impedance in athletes. Med Sci Sports Exerc. 1998..
15. Fluid Shifts and Muscle Loss in Critical Care: Accuracy of Ultrasound Versus Bioelectrical Impedance Analysis. Nutrients. 2025..
16. Bioimpedance analysis is safe in patients with implanted cardiac devices. Clin Nutr. 2018..
17. Ohkawara K et al. A dose-response relation between aerobic exercise and visceral fat reduction. Int J Obes. 2007..
18. Jayedi A et al. Aerobic Exercise and Weight Loss in Adults: A Systematic Review. JAMA Network Open. 2024..
19. Theorell-Haglöw J et al. Change in sleep duration and visceral fat accumulation over 6 years in adults. Obesity (Silver Spring). 2014..
20. Knowledge mapping and bibliometric analysis of metabolic phenotypes in childhood and adolescent obesity. Front Public Health. 2025..
21. Selective SGLT2 inhibitors in MASLD/MASH: an outcome-specific systematic review and meta-analysis. Acta Diabetol. 2025..
22. Metabolic Dysfunction-Associated Steatotic Liver Disease and Respiratory Disorders. Curr Obes Rep. 2025..

Frequently Asked Questions